Fucoidan-Based Nanoparticles with Inherently Therapeutic Efficacy for Cancer Treatment
The anticancer properties of fucoidan have been widely studied in cancer research. However, the lack of safety information on the parenteral administration of fucoidan and its rapid clearance from the system have limited its application. Herein, we assessed the therapeutic efficacy and safety of fuc...
Main Authors: | Chih-Sheng Chiang, Bo-Jie Huang, Jui-Yu Chen, Wee Wei Chieng, Seh Hong Lim, Wei Lee, Weoi-Cherng Shyu, Long-Bin Jeng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/12/1986 |
Similar Items
-
Important Determinants for Fucoidan Bioactivity: A Critical Review of Structure-Function Relations and Extraction Methods for Fucose-Containing Sulfated Polysaccharides from Brown Seaweeds
by: Anne S. Meyer, et al.
Published: (2011-10-01) -
Modulation of T Cell Responses by Fucoidan to Inhibit Osteogenesis
by: Hailin Huang, et al.
Published: (2022-06-01) -
Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug—A Review
by: Jun-O Jin, et al.
Published: (2022-09-01) -
Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms
by: Aleksandra Citkowska, et al.
Published: (2019-08-01) -
Perspectives for the Use of Fucoidans in Clinical Oncology
by: Mikhail V. Kiselevskiy, et al.
Published: (2022-10-01)